AU Patent

AU2006209065B2 — Indole derivatives

Assigned to Tanabe Pharma Corp · Expires 2011-09-08 · 15y expired

What this patent protects

Indole derivatives of formula (I) or a pharmaceutically acceptable salt thereof: wherein R is halogen, or alkyl, R is hydrogen, or halogen, Ar is phenyl, or thienyl, which may be substituted with halogen, alkyl, alkoxy, alkylthio, etc.

USPTO Abstract

Indole derivatives of formula (I) or a pharmaceutically acceptable salt thereof: wherein R is halogen, or alkyl, R is hydrogen, or halogen, Ar is phenyl, or thienyl, which may be substituted with halogen, alkyl, alkoxy, alkylthio, etc.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006209065B2
Jurisdiction
AU
Classification
—
Expires
2011-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.